Technical Analysis for LIFE - aTyr Pharma, Inc.

Grade Last Price % Change Price Change
grade D 3.97 1.79% 0.07
LIFE closed up 1.79 percent on Tuesday, August 4, 2020, on 59 percent of normal volume. Its advance stalled at its 200 day moving average, an important long-term support / resistance line. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical LIFE trend table...

Date Alert Name Type % Chg
200 DMA Resistance Bearish 0.00%
Spinning Top Other 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
200 DMA Resistance Bearish 1.79%
Wide Bands Range Expansion 1.79%
Down 3 Days in a Row Weakness 1.79%
Down 4 Days in a Row Weakness 1.79%
Down 5 Days in a Row Weakness 1.79%
Oversold Stochastic Weakness 1.79%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

aTyr Pharma, Inc. engages in the discovery and clinical development of protein based therapeutics for patients suffering from severe and rare diseases. The company is developing Resolaris, which is in Phase Ib/II clinical trials in adult patients with facioscapulohumeral muscular dystrophy, a rare genetic myopathy with an immune component. Its products pipeline also includes Resolaris for treatment of patients with early onset facioscapulohumeral muscular dystrophy, a rare genetic myopathy with an immune component and limb-girdle muscular dystrophies, as well as rare pulmonary diseases with an immune component. In addition, the company is developing iMod.Fc, a preclinical immuno-modulatory domain program. The company was founded in 2005 and is headquartered in San Diego, California.
Organ Systems Muscular Dystrophy Dystrophy Severe And Rare Diseases Facioscapulohumeral Muscular Dystrophy Myopathy

Is LIFE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 7.62
52 Week Low 2.13
Average Volume 99,315
200-Day Moving Average 4.02
50-Day Moving Average 4.15
20-Day Moving Average 4.36
10-Day Moving Average 4.17
Average True Range 0.35
ADX 16.42
+DI 15.56
-DI 21.16
Chandelier Exit (Long, 3 ATRs ) 4.44
Chandelier Exit (Short, 3 ATRs ) 4.77
Upper Bollinger Band 5.18
Lower Bollinger Band 3.54
Percent B (%b) 0.26
BandWidth 37.73
MACD Line -0.06
MACD Signal Line 0.04
MACD Histogram -0.0966
Fundamentals Value
Market Cap 94.64 Million
Num Shares 23.8 Million
EPS -2.19
Price-to-Earnings (P/E) Ratio -1.81
Price-to-Sales 0.00
Price-to-Book 2.86
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.27
Resistance 3 (R3) 4.26 4.16 4.22
Resistance 2 (R2) 4.16 4.08 4.16 4.20
Resistance 1 (R1) 4.06 4.03 4.11 4.07 4.19
Pivot Point 3.96 3.96 3.98 3.96 3.96
Support 1 (S1) 3.86 3.88 3.91 3.87 3.75
Support 2 (S2) 3.76 3.83 3.76 3.74
Support 3 (S3) 3.66 3.76 3.72
Support 4 (S4) 3.67